Lataa...
Therapy for metastatic melanoma: the past, present, and future
Metastatic melanoma is the most aggressive form of skin cancer with a median overall survival of less than one year. Advancements in our understanding of how melanoma evades the immune system as well as the recognition that melanoma is a molecularly heterogeneous disease have led to major improvemen...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3308914/ https://ncbi.nlm.nih.gov/pubmed/22385436 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-10-23 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|